Table 1.
Global clinical and epidemiological characterization.
| n | % | |
|---|---|---|
| Gender | ||
| Female | 47 | 48 |
| Male | 51 | 52 |
| Age | ||
| 60 years or less | 80 | 81.6 |
| Over 60 years | 18 | 18.4 |
| Race | ||
| Caucasian | 91 | 92.9 |
| Non-Caucasian | 7 | 7.1 |
| Family cancer history | ||
| Present | 40 | 40.8 |
| Absent | 39 | 39.8 |
| Insufficient information | 19 | 19.4 |
| Cytogenetics | ||
| Good prognosis | 21 | 21.4 |
| Intermediary prognosis | 40 | 40.8 |
| Poor prognosis | 23 | 23.5 |
| Insufficient information | 14 | 14.3 |
| Translocation (15;17) | ||
| Present | 17 | 17.3 |
| Absent | 81 | 82.7 |
| Complete remission after first induction | ||
| Present | 46 | 46.9 |
| Absent | 43 | 43.9 |
| Insufficient information | 9 | 9.2 |
| White blood cell count | ||
| Lower than 30 × 109/L | 56 | 57.1 |
| Over than 30 × 109/L | 26 | 26.6 |
| Insufficient information | 16 | 16.3 |
| Type of leukemia | ||
| Primary | 61 | 62.2 |
| Secondary | 36 | 36.7 |
| Insufficient information | 1 | 1.1 |